You are here

Novel reporter cell lines for neurotoxicant assays

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43ES023718-01A1
Agency Tracking Number: R43ES023718
Amount: $225,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: NIEHS
Solicitation Number: PA14-071
Timeline
Solicitation Year: 2014
Award Year: 2014
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
201 West Second St.
Lexington, KY 40507-1112
United States
DUNS: 145182338
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 ERIC OSTERTAG
 (267) 259-1086
 ostertag@transposagenbio.com
Business Contact
 ERIC OSTERTAG
Phone: (859) 303-9442
Email: ostertag@transposagenbio.com
Research Institution
 Stub
Abstract

DESCRIPTION (provided by applicant): While it has been demonstrated that gene mutations are associated with an increasing number of neurodegenerative syndromes, environmental neurotoxicants remain a key factor in the etiology of many such diseases. For example, exposure to pesticides such as maneb and paraquat increase the risk of developing Parkinson's disease. Unfortunately, there is no optimal in vitro model system to assess the neurotoxic potential of compounds. As result, exposure to poorly characterized compounds represents a significant contributor to the development of environmentally-induced diseases. There is a compelling unmet need for in vitro models and endpoint assays that are cost-effective, accurate, predictive, and sensitive that would alsobe amenable to high throughput screening. In particular, there is a need to develop homogeneous in vitro screens that can be used in quantitative high-throughput screening to query large libraries of chemical compounds such as the 'Tox21 10K' chemical

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government